About Renovo
Renovo is a Healthcare company based in Manchester (United Kingdom) founded in 2000. Stem cell therapeutics for wound healing. Renovo has raised $36.2 million across 2 funding rounds from investors including J P Morgan, Atlas Venture and BioVeda Capital. Renovo offers products and services including Domain Quote Service. Its focus areas include Life Sciences, Wound Care and Drugs. Its legal entity is RENOVO LTD.
Company details
Renovo developed stem cell therapeutics for wound healing. Its lead candidate Juvista used embryonic stem cells to prevent scarring in surgical recovery, cosmetic surgery and burn victims. In June 2007, Shire acquired the US rights for the drug for 75M upfront, 50M equity stake and upto 700M in milestone payments. The deal was terminated after Juvista failed pivotal phase III trials.
- Headquarters Manchester, United Kingdom
- SectorsHealthcare
- Website renovo.com
- Social LinkedIn
- Legal Name Renovo Ltd
- Total Equity Funding$36.2M (USD)
in 2 rounds
- Latest Funding Round$3.2M (USD), Series B
Jan 2003
- InvestorsJ P Morgan
& 4 more
Products & Services of Renovo
Renovo offers a comprehensive portfolio of products and services, including Domain Quote Service.
Platform for requesting price quotes on domain names online
Funding Insights of Renovo
Renovo has successfully raised a total of $36.2M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $3.2 million completed in January 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.2M
- Total Rounds 2
- Last Round Series B — $3.2M
- First Round $33M
(Dec 2002)
- Investors Count 5
All 2 funding rounds of Renovo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2003 | $3.2M | Series B | – | – | |
| Dec 2002 | $33M | Series B | – | – |
5 investors in total: 5 institutional.
Investors in Renovo
Renovo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include J P Morgan, Atlas Venture and BioVeda Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| biovedavc.com | ||||
| carecapital.com | ||||
| healthcap.eu | ||||
Venture capital firm investing in life science and biotechnology sectors | 1980 | atlasventure.com | Cambridge, United States | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States |
Investor details for Renovo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Renovo
3 dated milestones of Renovo across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Renovo is founded.
- Funding First funding round of $33.0M.
- Funding Latest funding round, Series B, of $3.2M.
Web traffic of Renovo
Websites that share an audience with Renovo (renovo.com).
Websites whose visitors overlap most with Renovo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
renova.com | renova.com | 100% | #5,247,564 | – | |
| portola.com | 99% | View details | |||
ieb.fr | ieb.fr | 99% | – | ||
| biospecifics.com | 99% | View details | |||
| stiefel.com | 99% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Renovo
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Renovo
Renovo was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Renovo is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Renovo is a funded company, having raised a total of $36.2M across 2 funding rounds to date. The company's 1st funding round was a Series B of $33M, raised on Dec 2002.
Renovo developed stem cell therapeutics for wound healing. Its lead candidate Juvista used embryonic stem cells to prevent scarring in surgical recovery, cosmetic surgery and burn victims. In June 2007, Shire acquired the US rights for the drug for 75M upfront, 50M equity stake and upto 700M in milestone payments. The deal was terminated after Juvista failed pivotal phase III trials.
Renovo offers Domain Quote Service.
Renovo has 5 investors. Key investors include J P Morgan, Atlas Venture, BioVeda Capital, Care Capital, and Healthcap.
Renovo operates through Renovo Ltd.